Medication info
Heptacapsule

Heptacapsule

Prescription medicationHard capsule경구
Ingredient · strength
Biphenyl Dimethyl Dicarboxylate›12.5mg / 1 capsuleUrsodeoxycholic Acid›50mg / 1 capsule
Manufacturer / importer
(주)넥스팜코리아
Appearance
A hard capsule with a white upper and lower part containing white powder
Packaging
(For domestic use) 30 capsules/bottle, 300 capsules/bottle (For export) 30 capsules ((10 capsules/PTP)x3), 50 capsules ((10 capsules/PTP)x5), 100 capsules ((10 capsules/PTP)x10)
Approval status
Active

MFDS item code 201501407 · Approved 2015.03.17 · Insurance code 662503120

Summary

Main use
Inhibition of SGPT elevation in chronic persistent hepatitis
Who takes it
Adults
Adult dose
Typically, 1 capsule orally after meals, 3 times a day for adults.

Ingredients

Manufacturer
(주)넥스팜코리아

Efficacy & effects

Inhibition of SGPT elevation in chronic persistent hepatitis

  • Elevated SGPT
  • chronic persistent hepatitis
View approved original text

If the patient is diagnosed with chronic persistent hepatitis with persistently elevated SGPT levels, this medication helps improve liver function and reduce inflammation, contributing to the recovery of liver health. It is used in chronic persistent hepatitis to reduce liver damage and help maintain normal function.

How to take

Adult dose

Typically, 1 capsule orally after meals, 3 times a day for adults.

Precautions

This medication should not be used in patients with complete biliary obstruction. Additionally, this medication contains lactose, thus it is safe not to administer it to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. This medication should be administered cautiously to patients with chronic active hepatitis, liver cirrhosis, hypokalemia, severe pancreatic diseases, peptic ulcer disease, and cholelithiasis. While taking this medication, gastrointestinal symptoms such as diarrhea, nausea, and vomiting may occasionally occur, and rarely abdominal pain, constipation, heartburn, and upper gastrointestinal discomfort may also be experienced. Moreover, hypersensitivity reactions such as itching or rash may occur, and skin rash may occasionally appear, but symptoms generally resolve with the use of antihistamines. Transient jaundice may occur; in this case, discontinuation of the medication or the use of jaundice treatment drugs may improve symptoms. Rarely, systemic fatigue or dizziness may occur, so caution is advised. Serious side effects, including liver cirrhosis, ascites, and acute hepatitis C, have been reported in a six-year post-marketing survey; the full correlation with this medication cannot be completely ruled out. Dosage and administration must strictly follow guidelines, and if symptoms do not improve after a maximum of 8 weeks or if abnormal symptoms arise, discontinue use and consult a physician or pharmacist. It is important to keep this medication in a safe place out of reach of children. Women who are pregnant or may become pregnant should refrain from taking this medication as it may be harmful to the fetus. Additionally, caution is necessary when taking this medication alongside oral diabetes medications as it may enhance the effects of the diabetes medications, and consultation with healthcare professionals is required.

Side effects and when to seek care immediately

Serious side effects

  • Transient jaundice: classified as liver abnormality (jaundice)
  • Liver cirrhosis, ascites, acute hepatitis C: significant adverse drug reactions

Mild side effects

  • Gastrointestinal symptoms: diarrhea, nausea, vomiting, abdominal pain, constipation, heartburn, upper gastrointestinal discomfort
  • Hypersensitivity: itching, rash, urticaria
  • Transient jaundice
  • Systemic fatigue, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air entry, preferably at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

A hard capsule with a white upper and lower part containing white powder

Package unit

(For domestic use) 30 capsules/bottle, 300 capsules/bottle (For export) 30 capsules ((10 capsules/PTP)x3), 50 capsules ((10 capsules/PTP)x5), 100 capsules ((10 capsules/PTP)x10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.